Data Epilepsy Events Topical 
Canna Law Blog
JUNE 5, 2019
The objective of the meeting was to gather scientific data and information about the safety, manufacturing, product quality, marketing, labeling and sale of these products. Accordingly, CBD cannot be marketed simultaneously as a food/dietary supplement and a drug.u. PROPONENTS AND OPPONENTS. In addition, the U.S.
Cannabis Law Report
JANUARY 27, 2020
The US Food and Drug Administration (FDA) asserts its case clearly on its website, emphasising that it has approved only one product, and that’s a prescription drug to treat two rare forms of epilepsy. It appeared comprehensive and relied on data mainly from food authorities but also from industry. Alarm 2: EFSA, EU.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
MAY 6, 2022
Examples of sellers’ language the FDA views as illegal are the following: “Our line of …CBD oil … is great for insomnia, epilepsy, MS, schizophrenia, and chronic pain.”. Pre-clinical data support the possible use of CBD with Panic Disorder…Bipolar Disorder.”. High level CBD can help manage symptoms of psychosis.”.
Project CBD
FEBRUARY 28, 2023
HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Consumers spent roughly $31.3 increase in annual sales. Accessed July 25, 2021.
Cannabis Law Report
DECEMBER 20, 2021
Data To Support Regulatory Filings in the United States. About Epoladerm™ Virpax Pharmaceuticals is developing Epoladerm™ (diclofenac epolamine), an investigational analgesic supplied in a pre-filled device for administration as a topical spray film to manage chronic pain associated with osteoarthritis of the knee.
Cannabis Law Report
OCTOBER 6, 2021
Preliminary in-vitro, ex-vivo, and in-vivo data demonstrated that AnQlar inhibits replication of SARS-CoV-2 and may inhibit viral spread as well as viral brain load at non-toxic concentrations. Epoladerm™ is a topical diclofenac spray film formulation being developed to manage osteoarthritis pain. About Virpax Pharmaceuticals.
Cannabis Law Report
OCTOBER 1, 2021
Epoladerm™ is a topical diclofenac metered-dose spray film formulation being developed to manage acute musculoskeletal pain and osteoarthritis. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. About Channelchek. Betsy Brod.
Expert insights. Personalized for you.
56 
Let's personalize your content